Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7439 p188
17 February 2007

This article
Reprint   Photocopy

PDF 90K, Acrobat Reader

Letters

• Community pharmacy (3)
• Pfizer proposals
• COPD
• Statins
• Complementary medicine
• NHS
• Physician-assisted suicide (3)
• Prescribing
• Northern Ireland
• Medicines recycling
• Retention fees
• Reciprocity


Letters to the Editor

Complementary medicine

Need for research into safety and efficacy

From Professor E. Ernst

The article on frequently asked questions about medicines was most revealing (PJ, 3 February, p140).

In particular, I was surprised how many of these questions relate to complementary and alternative medicine (CAM). This indicates a level of uncertainty which, I think, needs addressing by adequate research and reliable information. Sadly neither is being pursued at present by the UK government.

In 2000, the House of Lords issued a report on CAM which recommended more research, primarily of the safety and efficacy of CAM, and better information for all concerned.1

The Government did not follow these recommendations. Instead of rigorous research into safety and efficacy issues, it initiated several PhD projects mostly on the sociology of CAM.2

Instead of adequate patient information, it funded a patient guide, which reads like a promotional brochure for CAM and tells us nothing about efficacy and little about safety. In fact, a draft of this guide did contain some rudimentary efficacy data. They were, however, omitted in the final text.

The Department of Health later claimed that such information was never part of the contract with the Prince of Wales Foundation for Integrated Health, the organisation responsible for the guide.3

Wills and Campbell have convincingly demonstrated that questions about CAM are among those most frequently asked by patients. Is it therefore not time that the DoH helps us to get in a position from where we can answer them reliably?

Edzard Ernst
Director of Complementary Medicine
Peninsula Medical School
Exeter


References

1. House of Lords, Science and Technology Committee Sixth Report. 2000

2. Garrow J, Glenn S, Wilson P, Kleijnen J, Walton J, Colquhoun D. UK government funds CAM research. Focus on Alternative and Complementary Therapy 2003;8: 397–401

3. The Prince of Wales’ Foundation for Integrated Healthcare. Complementary Healthcare: a guide for patients. London: The Foundation; 2005

Send your letter to The Editor

Previous Topic (Statins)
Next Topic (NHS)

Back to Top


©The Pharmaceutical Journal